India / EMA Suspends Synapse Labs-Tested Generics: Another Setback in India’s Pursuit of Quality
In the latest blow to Indian pharma’s reputation, the European Medicines Agency (EMA) has recommended the suspension of marketing authorisations for a large number of generics tested by Indian CRO…